Representative Michael C Burgess Stocks

On October 2, 2024, Representative Michael C Burgess of US Congress acquired $15k to $50k worth of Illumina's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are 41 other transactions of Michael C Burgess.
2024-10-02Acquired $15K to $50KILMN IlluminaInsidersVerify
2024-10-01Acquired $15K to $50KILMN IlluminaInsidersVerify
2024-09-25Acquired $15K to $50KILMN IlluminaInsidersVerify
2024-09-24Acquired $15K to $50KILMN IlluminaInsidersVerify
2024-08-12Acquired $15K to $50KRY Royal BankInsidersVerify
2024-07-31Acquired Under $15KRY Royal BankInsidersVerify
2024-05-02Acquired Under $15KIBM International BusinessInsidersVerify
2024-04-10Acquired $15K to $50KXOM Exxon Mobil CorpInsidersVerify
2024-03-22Acquired Under $15KWBA Walgreens Boots AllianceInsidersVerify
2024-03-07Acquired $15K to $50KBBY Best BuyInsidersVerify
2024-02-05Acquired $15K to $50KBX Blackstone GroupInsidersVerify
2024-01-22Acquired $15K to $50KXOM Exxon Mobil CorpInsidersVerify
2024-01-08Acquired Under $15KUPS United Parcel ServiceInsidersVerify
2023-12-18Acquired Under $15KABBV AbbVie IncInsidersVerify
2023-10-03Acquired Under $15KMRK Merck CompanyInsidersVerify
2023-09-06Acquired Under $15KAMD Advanced Micro DevicesInsidersVerify
2023-09-05Acquired $15K to $50KABBV AbbVie IncInsidersVerify
2023-08-08Acquired $15K to $50KBX Blackstone GroupInsidersVerify
2023-07-18Acquired $15K to $50KABBV AbbVie IncInsidersVerify
2023-06-15Acquired Under $15KBX Blackstone GroupInsidersVerify
2023-04-14Acquired $15K to $50KAMGN Amgen IncInsidersVerify
2023-03-14Acquired $15K to $50KBX Blackstone GroupInsidersVerify
2023-03-03Acquired $15K to $50KMSFT MicrosoftInsidersVerify
2023-02-09Acquired $15K to $50KDIS Walt DisneyInsidersVerify
2023-01-25Acquired $100K to $250KSYK StrykerInsidersVerify
2022-12-08Acquired $15K to $50KDIS Walt DisneyInsidersVerify
2022-11-29Acquired Under $15KSYK StrykerInsidersVerify
2022-11-15Acquired Under $15KSYK StrykerInsidersVerify
2022-11-02Acquired Under $15KMS Morgan StanleyInsidersVerify
2022-09-20Acquired Under $15KSYK StrykerInsidersVerify
2022-08-05Acquired $15K to $50KAMZN Amazon IncInsidersVerify
2022-06-27Acquired $15K to $50KAMZN Amazon IncInsidersVerify
2022-06-03Acquired Under $15KSYK StrykerInsidersVerify
2022-04-29Acquired Under $15KSYK StrykerInsidersVerify
2022-04-15Acquired Under $15KSYK StrykerInsidersVerify
2022-03-23Acquired Under $15KSYK StrykerInsidersVerify
2022-03-03Acquired Under $15KF Ford MotorInsidersVerify
2022-02-10Acquired Under $15KDIS Walt DisneyInsidersVerify
2022-01-27Acquired Under $15KABT Abbott LaboratoriesInsidersVerify
2021-12-31Acquired Under $15KMSFT MicrosoftInsidersVerify
2021-11-17Acquired Under $15KSYK StrykerInsidersVerify
View All Elective Officials  

Risk-return Landscape of Michael C Burgess's positions

  Expected Return   
       Risk  

Assets Rated by Market Efficiency

Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
EfficiencyMarket RiskExp ReturnPrice
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.